HK1077749A1 - Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera - Google Patents

Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Info

Publication number
HK1077749A1
HK1077749A1 HK05109887A HK05109887A HK1077749A1 HK 1077749 A1 HK1077749 A1 HK 1077749A1 HK 05109887 A HK05109887 A HK 05109887A HK 05109887 A HK05109887 A HK 05109887A HK 1077749 A1 HK1077749 A1 HK 1077749A1
Authority
HK
Hong Kong
Prior art keywords
acylaminoalkenylene
viscera
amide derivatives
motility disorders
functional motility
Prior art date
Application number
HK05109887A
Other languages
English (en)
Inventor
John R Fozard
Eckhard Weber
Hans-Juergen Pfannkuche
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of HK1077749A1 publication Critical patent/HK1077749A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
HK05109887A 2002-02-08 2005-11-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera HK1077749A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Publications (1)

Publication Number Publication Date
HK1077749A1 true HK1077749A1 (en) 2006-02-24

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05109887A HK1077749A1 (en) 2002-02-08 2005-11-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Country Status (19)

Country Link
US (2) US20050203164A1 (xx)
EP (2) EP1476167A1 (xx)
JP (2) JP2005516994A (xx)
KR (2) KR20100100994A (xx)
CN (1) CN1301714C (xx)
AU (1) AU2003244446B2 (xx)
BR (1) BR0307479A (xx)
CA (1) CA2471964A1 (xx)
GB (1) GB0203061D0 (xx)
HK (1) HK1077749A1 (xx)
IL (2) IL162816A0 (xx)
MX (1) MXPA04007640A (xx)
NO (1) NO20043735L (xx)
NZ (1) NZ534231A (xx)
PL (1) PL370255A1 (xx)
RU (1) RU2353356C2 (xx)
TW (1) TWI330177B (xx)
WO (1) WO2003066062A1 (xx)
ZA (1) ZA200404960B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
US20080234345A1 (en) 2006-09-08 2008-09-25 Gene Logic Inc. Method for reducing or alleviating inflammation in the digestive tract

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
EP0810991B1 (en) * 1995-02-22 1999-04-14 Novartis AG 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
IL133357A (en) * 1997-07-02 2003-12-10 Merck & Co Inc Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r)- (3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(s)-(4-fluoro) phenyl-4- (3-5(-oxo-1h, 4h-1,2,4-triazolo) methylmorpholine
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
WO2002051440A1 (fr) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Medicaments de combinaison
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
AU2003244446A1 (en) 2003-09-02
WO2003066062A1 (en) 2003-08-14
NZ534231A (en) 2007-02-23
JP2010241835A (ja) 2010-10-28
MXPA04007640A (es) 2004-11-10
PL370255A1 (en) 2005-05-16
GB0203061D0 (en) 2002-03-27
US20050203164A1 (en) 2005-09-15
EP1476167A1 (en) 2004-11-17
KR20100100994A (ko) 2010-09-15
CN1301714C (zh) 2007-02-28
CA2471964A1 (en) 2003-08-14
TW200302818A (en) 2003-08-16
EP2216025A2 (en) 2010-08-11
ZA200404960B (en) 2006-05-31
BR0307479A (pt) 2004-12-07
CN1627947A (zh) 2005-06-15
JP2005516994A (ja) 2005-06-09
IL162816A (en) 2010-11-30
KR20040081492A (ko) 2004-09-21
NO20043735L (no) 2004-09-07
AU2003244446B2 (en) 2006-08-10
IL162816A0 (en) 2005-11-20
US20070293473A1 (en) 2007-12-20
TWI330177B (en) 2010-09-11
RU2004127132A (ru) 2005-06-10
EP2216025A3 (en) 2010-11-10
RU2353356C2 (ru) 2009-04-27

Similar Documents

Publication Publication Date Title
AP2004003110A0 (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
AP1850A (en) Spiroindolineplperidine derivatives
EG24050A (en) Heterocylocarboxamide derivatives
IL189657A0 (en) N-phenyl-2-pyrimidine-amine derivatives
HK1077068A1 (en) Azolidinone-vinyl fused-benzene derivatives
IL166121A0 (en) Indole-3-sulphur derivatives
EP1522540A4 (en) AZAARENE DERIVATIVES
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IL166426A0 (en) N-biarylmethyl aminocycloalkanecarboxamide derivatives
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003222659A8 (en) 23-o-substituted 5-o-mycaminosyltylonide derivatives
AU2003297612A8 (en) 2-substituted-3-propenamide derivatives and methods of using the same
HK1077749A1 (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
GB2403474B (en) Amide derivatives
GB0316910D0 (en) Fluorocombretastatin and derivatives thereof
AU2003235889A8 (en) Amide derivatives
EP1531854A4 (en) O-DERIVATED NOCATHIACIN DERIVATIVES
AU2003205963A8 (en) Azaphenylalanine derivatives and their use as antithrombotic agents
GB0213488D0 (en) 2-Naphthamide derivatives
GB0307231D0 (en) 7-Nitroindoline derivatives and their uses
GB0221270D0 (en) Moke 2
AU2003243397A8 (en) Homo-camptothecin derivatives
ZA200500735B (en) Novel quinuclidine derivatives and their use
GB0208846D0 (en) The moke
GB0209685D0 (en) Towel

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120207